Portfolio (Quarterly)
Guide ↗
Crestline Management, L.P.
· CIK 0001536054| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 2,810,732.0 | $46.4M | 87.02% | NEW | — | $16.51 | +12.9% |
| 2 | SANA | SANA BIOTECHNOLOGY INC | Healthcare | 1,220,937.0 | $5.0M | 9.32% | NEW | — | $4.07 | -24.6% |
| 3 | EGHT | 8X8 INC NEW | Technology | 990,580.0 | $2.0M | 3.66% | NEW | — | $1.97 | +11.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.3%
Technology
3.7%